The use of advanced biological and tissue-engineered wound products
Intended for healthcare professionals
Art & Science Previous     Next

The use of advanced biological and tissue-engineered wound products

Mark Collier Lead nurse consultant in tissue viability, United Lincolnshire Hospitals NHS Trust, Boston, Lincolnshire

This article aims to reintroduce readers to biologically based and tissue-engineered wound management products. Indications for their use in clinical practice are suggested. It also examines two well-established wound management interventions, topical negative pressure therapy and larval therapy, which could have a positive effect on the outcome of biologically based and tissue-engineered wound management products.

Nursing Standard. 21, 7, 68-76. doi: 10.7748/ns2006.10.21.7.68.c6364

Correspondence

mark.collier@ulh.nhs.uk

Peer review

This article has been subject to double blind peer review

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more